NDC product
GRANULE, FOR SUSPENSION · Astellas Pharma Inc.
NDC 12838-1330 · Astellas Pharma Inc.
Key facts
| Product NDC | 12838-1330 |
|---|---|
| Nonproprietary name | Tacrolimus |
| Substances | TACROLIMUS |
| Dosage form | GRANULE, FOR SUSPENSION |
| Labeler | Astellas Pharma Inc. |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | May 24, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: